Vestibular Migraine
Dizziness, motion sensitivity, and imbalance driven by migraine physiology — with or without headache.
Vestibular migraine is now recognized as one of the most common causes of episodic dizziness in adults, second only to BPPV. Population studies estimate a lifetime prevalence of roughly 1 percent in the general population, with a strong female predominance. Despite that prevalence, vestibular migraine is one of the most under-diagnosed vestibular conditions, largely because a substantial minority of episodes occur without any headache at all.
The core insight of vestibular migraine is that migraine is a whole-brain disorder, not just a headache. The same neurologic sensitization that produces throbbing head pain in classical migraine can produce vertigo, motion sensitivity, visual overwhelm, brain fog, and unsteadiness, sometimes with the headache, sometimes without it, and sometimes years before a patient ever has a real migraine.
The International Headache Society and Barany Society co-published the diagnostic criteria for vestibular migraine in 2012, updated in 2022. The criteria are clinical, not imaging-based. A patient qualifies with a history of migraine, at least five episodes of vestibular symptoms of moderate-to-severe intensity lasting 5 minutes to 72 hours, and at least half of episodes accompanied by migraine features (headache, photophobia, phonophobia, visual aura).
For patients, the practical impact is enormous. Vestibular migraine is often mislabeled as anxiety, as Meniere's disease, or as a vague inner ear problem. Recognizing what it actually is unlocks a treatment approach that is very different from, and much more effective than, anything a generic dizziness workup would produce.
Symptoms of Vestibular Migraine
Episode length is the diagnostic clue. Vertigo lasting seconds is BPPV. Vertigo lasting weeks continuously is neuritis. Vertigo lasting between 5 minutes and 72 hours, in recurrent episodes, is the vestibular migraine window.
Cars, boats, elevators, and busy visual environments become intolerable. Many patients avoid driving on the highway or shopping in warehouse-style stores.
Fluorescent lights, striped patterns, scrolling on a phone, and grocery-store aisles trigger dizziness. This is called visual dependence and is measurable.
A persistent walking-on-a-boat feeling between episodes, often mistaken for anxiety or an inner-ear problem.
The migrainous brain is inefficient during and between episodes. Word-finding, attention, and processing speed all take a hit.
Even without a headache, phonophobia and photophobia are common, a clue that the underlying process is migrainous.
Roughly half of vestibular migraine episodes involve a headache. The other half do not, which is why so many patients are missed for years.
Diagnosis
Diagnosis is clinical, based on the ICHD/Barany criteria above. There is no blood test, no MRI finding, and no vestibular function test that confirms vestibular migraine. What confirms it is a careful history, a normal or near-normal vestibular exam between episodes, and the exclusion of Meniere's disease (which involves hearing loss) and structural causes.
Two conditions coexist with vestibular migraine surprisingly often: BPPV and PPPD (persistent postural-perceptual dizziness). It is not uncommon for a patient to have vestibular migraine as their primary problem and PPPD as a secondary sensitization layered on top. Treating only one will produce partial results.
Vestibular function testing (VNG, rotary chair, VEMP) is usually normal or only subtly abnormal in vestibular migraine, and is not required for diagnosis. It is most useful when the clinical picture is atypical.
Treatment
The migraine brain rewards regularity. Consistent sleep, consistent meals, consistent hydration, and reasonable caffeine control produce measurable reductions in episode frequency for most patients. This is not a placebo; it is well-established migraine physiology.
Progressive habituation, gaze stabilization, and graded visual-motion exposure are the core physical therapy interventions. Multiple randomized trials show meaningful benefit, especially for the motion-sensitivity and visual-dependence components.
For patients with frequent or disabling episodes, standard migraine preventives, nortriptyline, topiramate, propranolol, venlafaxine, and the newer CGRP monoclonal antibodies, have evidence in vestibular migraine specifically. We do not prescribe medication, but we coordinate closely with the patient's physician.
Vestibular migraine has a strong sensitization and behavioral avoidance component. Structured graded exposure, with a therapist who understands both vestibular and migraine physiology, is more effective than either general balance PT or generic migraine care alone.
Meclizine used as-needed is fine for a bad episode. Meclizine used daily is a bad idea; it delays central compensation and does not treat the underlying migraine process. Vestibular training that just consists of head-shaking exercises is not enough; the visual and cognitive components have to be addressed too.
Recovery and outlook
Vestibular migraine is a chronic condition, but it is highly manageable. The realistic expectation is not cure but meaningful reduction in episode frequency, severity, and duration, plus tools to shorten the episodes you still have. Most patients report the majority of gains in 6 to 12 weeks of consistent care.
The single strongest predictor of a good outcome is combining lifestyle work, vestibular rehab, and appropriate preventive medication when needed. Any one of those three alone tends to plateau. Together, they compound.
Long-term, many patients enter periods of complete or near-complete remission, punctuated by occasional flares during high-stress or high-trigger seasons. Knowing what it is, and having a plan for flares, converts the condition from disabling to manageable.
Frequently asked
Yes. Roughly half of episodes have no headache. This is the biggest reason vestibular migraine is missed for years.
Meniere's involves recurrent hearing loss and tinnitus with vertigo attacks. Vestibular migraine does not affect hearing. When the picture is mixed, an audiogram helps.
No. It is disabling but not dangerous. It does not damage the brain or the inner ear.
No, but preventives can substantially reduce episode frequency. The most durable results come from combining medication with vestibular rehab and lifestyle work.
Yes. Multiple randomized trials show benefit in motion sensitivity, visual dependence, and functional balance in vestibular migraine specifically.
Most patients see clear improvement in 6 to 12 weeks of consistent care.
Yes: vestibular migraine tends to run in cycles across a lifetime, often flaring in perimenopause and around major stressors. Having tools you already know how to use makes flares much shorter.
Research and references
The 2022 Barany Society / IHS consensus criteria, the current diagnostic standard.
Systematic review supporting vestibular rehab as an effective component of vestibular migraine management.
Cochrane review on preventive medications; guidance for physician co-management.
Research references are provided for education. This page is not medical advice; it is an evidence-based summary of published vestibular literature.
Also treating
You don't have to live this way.
Book a free 15-minute consultation with a Doctor of Physical Therapy. No commitment — just clarity.